Ejaculation frequency and subsequent risk of prostate cancer - PubMed (original) (raw)
Ejaculation frequency and subsequent risk of prostate cancer
Michael F Leitzmann et al. JAMA. 2004.
Abstract
Context: Sexual activity has been hypothesized to play a role in the development of prostate cancer, but epidemiological data are virtually limited to case-control studies, which may be prone to bias because recall among individuals with prostate cancer could be distorted as a consequence of prostate malignancy or ongoing therapy.
Objective: To examine the association between ejaculation frequency, which includes sexual intercourse, nocturnal emission, and masturbation and risk of prostate cancer.
Design, setting, and participants: Prospective study using follow-up data from the Health Professionals Follow-up Study (February 1, 1992, through January 31, 2000) of 29 342 US men aged 46 to 81 years, who provided information on history of ejaculation frequency on a self-administered questionnaire in 1992 and responded to follow-up questionnaires every 2 years to 2000. Ejaculation frequency was assessed by asking participants to report the average number of ejaculations they had per month during the ages of 20 to 29 years, 40 to 49 years, and during the past year (1991).
Main outcome measure: Incidence of total prostate cancer.
Results: During 222 426 person-years of follow-up, there were 1449 new cases of total prostate cancer, 953 organ-confined cases, and 147 advanced cases of prostate cancer. Most categories of ejaculation frequency were unrelated to risk of prostate cancer. However, high ejaculation frequency was related to decreased risk of total prostate cancer. The multivariate relative risks for men reporting 21 or more ejaculations per month compared with men reporting 4 to 7 ejaculations per month at ages 20 to 29 years were 0.89 (95% confidence interval [CI], 0.73-1.10); ages 40 to 49 years, 0.68 (95% CI, 0.53-0.86); previous year, 0.49 (95% CI, 0.27-0.88); and averaged across a lifetime, 0.67 (95% CI, 0.51-0.89). Similar associations were observed for organ-confined prostate cancer. Ejaculation frequency was not statistically significantly associated with risk of advanced prostate cancer.
Conclusions: Our results suggest that ejaculation frequency is not related to increased risk of prostate cancer.
Comment in
- Frequency of ejaculation and risk of prostate cancer.
Giles GG, Severi G, English DR, Hopper JL. Giles GG, et al. JAMA. 2004 Jul 21;292(3):329; author reply 329. doi: 10.1001/jama.292.3.329-a. JAMA. 2004. PMID: 15265846 No abstract available.
Similar articles
- Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up.
Rider JR, Wilson KM, Sinnott JA, Kelly RS, Mucci LA, Giovannucci EL. Rider JR, et al. Eur Urol. 2016 Dec;70(6):974-982. doi: 10.1016/j.eururo.2016.03.027. Epub 2016 Mar 28. Eur Urol. 2016. PMID: 27033442 Free PMC article. - Statin drugs and risk of advanced prostate cancer.
Platz EA, Leitzmann MF, Visvanathan K, Rimm EB, Stampfer MJ, Willett WC, Giovannucci E. Platz EA, et al. J Natl Cancer Inst. 2006 Dec 20;98(24):1819-25. doi: 10.1093/jnci/djj499. J Natl Cancer Inst. 2006. PMID: 17179483 - Ejaculatory frequency and the risk of aggressive prostate cancer: Findings from a case-control study.
Papa NP, MacInnis RJ, English DR, Bolton D, Davis ID, Lawrentschuk N, Millar JL, Pedersen J, Severi G, Southey MC, Hopper JL, Giles GG. Papa NP, et al. Urol Oncol. 2017 Aug;35(8):530.e7-530.e13. doi: 10.1016/j.urolonc.2017.03.007. Epub 2017 Mar 27. Urol Oncol. 2017. PMID: 28359743 - Evidence for Masturbation and Prostate Cancer Risk: Do We Have a Verdict?
Aboul-Enein BH, Bernstein J, Ross MW. Aboul-Enein BH, et al. Sex Med Rev. 2016 Jul;4(3):229-234. doi: 10.1016/j.sxmr.2016.02.006. Epub 2016 Mar 23. Sex Med Rev. 2016. PMID: 27871956 Review. - Ejaculation Frequency and Prostate Cancer Risk: A Narrative Review of Current Evidence.
Kokori E, Olatunji G, Isarinade DT, Aboje JE, Ogieuhi IJ, Lawal ZD, Woldehana NA, Nazar MW, Scott GY, Aderinto N. Kokori E, et al. Clin Genitourin Cancer. 2024 Jun;22(3):102043. doi: 10.1016/j.clgc.2024.01.015. Epub 2024 Feb 1. Clin Genitourin Cancer. 2024. PMID: 38430857 Review.
Cited by
- Spermiogram and sperm head morphometry assessed by multivariate cluster analysis results during adolescence (12-18 years) and the effect of varicocele.
Vásquez F, Soler C, Camps P, Valverde A, García-Molina A. Vásquez F, et al. Asian J Androl. 2016 Nov-Dec;18(6):824-830. doi: 10.4103/1008-682X.186873. Asian J Androl. 2016. PMID: 27751986 Free PMC article. - Vasectomy and risk of prostate cancer: population based matched cohort study.
Nayan M, Hamilton RJ, Macdonald EM, Li Q, Mamdani MM, Earle CC, Kulkarni GS, Jarvi KA, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network (CDSERN). Nayan M, et al. BMJ. 2016 Nov 3;355:i5546. doi: 10.1136/bmj.i5546. BMJ. 2016. PMID: 27811008 Free PMC article. - Application of Anti-Inflammatory Agents in Prostate Cancer.
Hatano K, Fujita K, Nonomura N. Hatano K, et al. J Clin Med. 2020 Aug 18;9(8):2680. doi: 10.3390/jcm9082680. J Clin Med. 2020. PMID: 32824865 Free PMC article. Review. - Epidemiology of Prostate Cancer.
Rawla P. Rawla P. World J Oncol. 2019 Apr;10(2):63-89. doi: 10.14740/wjon1191. Epub 2019 Apr 20. World J Oncol. 2019. PMID: 31068988 Free PMC article. Review. - The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective.
Phua TJ. Phua TJ. Medicines (Basel). 2021 Jun 11;8(6):30. doi: 10.3390/medicines8060030. Medicines (Basel). 2021. PMID: 34208086 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous